Description
GLYTINA M1
Glimepiride IP 2mg/1mg + Metformin Hydrochloride IP 500mg
(As Prolonged Release Form Tablets IP)
Glimepiride
-
Effective, safe, and well tolerated as a short-term intensive treatment in newly diagnosed type 2 diabetic patients.
-
A combination of glimepiride with metformin achieves good glycemic control with a better tolerability profile.
Metformin
-
A first-line antihyperglycemic agent commonly prescribed in type 2 diabetes mellitus (T2DM).
-
Improves carbohydrate and lipid metabolism and shows pronounced cardio and neuroprotective effects.
Control Sugar… Enhances Quality of Life
Company: NAMANIDHI PHARMACEUTICAL PVT. LTD.
